NADPH oxidase (NOX) is a multicomponent enzyme complex that generates reactive oxygen species (ROS) in response to a wide range of stimuli. ROS is involved as key secondary messengers in numerous signaling pathways, and NADPH oxidases complex has been increasingly recognized as key elements of intracellular signaling of hepatic fibrogenesis. In the liver, NADPH oxidase is functionally expressed both in the phagocytic form and in the non-phagocytic form. The non-phagocytic NADPH oxidase complex is structurally and functionally similar to the phagocytic NADPH, resulting in reduction of molecular oxygen to generate superoxide. There are six homologous NOX proteins in the non-phagocytic forms of NADPH oxidase. An emerging concept is that both phagocytic and nonphagocytic NADPH oxidase components in hepatic stellate cells (HSCs) mediate hepatic fibrosis, suggesting its potential role as a pharmacological target for anti-fibrotic therapy. The molecular components and signaling pathways of various NADPH oxidase homologues that are critical for the fibrotic activity in HSCs need to be more clearly identified. (Korean J Hepatol 2011;17:251-257)
INTRODUCTION
Chronic hepatic inflammation which is caused by excessive alcoholic consumption, hepatitis B or C virus, and non-alcoholic steatohepatitis results in hepatic fibrosis. 1 The terminal outcome of liver fibrosis is liver cirrhosis, characterized by excessive deposition of extracellular matrix proteins and the appearance of regenerative nodules, accompanied by hepatic failure, portal hypertention and hepatocellular carcinoma.
Portal hypertension may cause serious complications such as esophageal variceal bleeding, ascites, and hepatic encephalopathy that are the major causes of death in cirrhotic patients. However, there is no effective anti-fibrotic therapy to treat or reverse hepatic fibrosis and liver cirrhosis.
Therefore there is an urgent need to develop anti-fibrotic agent through the research for the molecular pathogenesis of hepatic fibrogenesis.
The hepatic stellate cell (HSC) is the main fibrogenic cell type in the injured liver and it also has been identified as an important effector in liver inflammation. 1 Reactive oxygen species (ROS) are involved as key secondary messengers in numerous signaling pathways including (homologue of p67 phox ) for enzyme activation. 12 In contrast, NOX4 requires only p22 phox without recruitment of cytosolic regulatory components to exert its enzymatic activity. 13 All NOX enzymes are able to catalyze the reduction of molecular oxygen to superoxide, but there are key differences in their activation, subunit composition, localization, and expression ( Table 1 , Fig. 1 ).
14 NADPH oxidase-mediated ROS generation and human diseases
Chronic granulomatous disease (CGD) has been described for several decades as a human disease resulting from defects in NOX complex. 15 The genetic defect of phagocytic NOX activity results in an inability to produce the superoxide anion necessary for killing bacteria and fungi by neutophils and phagocytes. The patients with CGD predispose to serious bacterial and fungal infections as well as granulomatous complications. It has been reported that at least 5 different genes involved in NOX activity may cause CGD. 15 The gene mutation of NOX2 on the X chromosome account for about 17 It was reported that oxidative damage is increased in both sporadic and familial form of ALS which is associated with mutations of SOD1. 18 In a SOD1 G93A transgenic mouse, an animal model of ALS, both NOX1 and NOX2 are involved in disease progression. 19, 20 In ALS pathogenesis, the activation of proinflammatory transcription factor NF-κB by TNF-α and IL-1β has been reported to involve NOX. 17 More recently, the important role of neuronal inflammation associated with redox-active signaling endosomes (redoxosomes) has been reported. 21 After TNF-α or IL-1β stimulation, dynamin-dependent co-endocytosis of the ligand-activated receptor and NOX complexes occur. 22, 23 As a next step, SOD1 is recruited to the redoxosome, where it binds to Rac1 and stabilizes the GTP-bound active form of Rac1. and Rac1 activation in redoxosome. 24 Taken together, mutations in SOD1 leads to increased NOX dependent ROS production and hyperactivation of proinflamamtory signaling that can kill motor neurons to develop ALS, where endosomal NOX regulation by SOD1/Rac1 interaction seems to be critical. 17 The possible disturbance of the above self-regulated redox signaling for NOX-derived ROS production may also be implicated in hepatic fibrogenesis. However, the detailed intracellular signaling of NOX-mediated superoxide production and subsequent conversion to H2O2 in HSCs is largely unknown.
Angiotensin II induces hepatic fibrosis via NADPH oxidase activation in hepatic stellate cells Another integral component required for the activation of NOX is Rac1. Rac1 is a member of the Rho family of small
GTPase proteins that regulates cell proliferation and dynamic reorganization of the actin cytoskeleton. 43 We reported that both NOX1 and NOX2 proteins are upregulated in the fibrotic liver. In particular, non-phagocytic 
